Australian Clinical Labs Limited (ACL) to Issue Interim Dividend of $0.03 on April 25th

Australian Clinical Labs Limited (ASX:ACL) declared a interim dividend on Wednesday, March 27th, MarketIndexAU reports. Stockholders of record on Thursday, April 25th will be given a dividend of 0.03 per share on Thursday, April 25th. This represents a dividend yield of 1.1%. The ex-dividend date is Wednesday, March 27th.

Australian Clinical Labs Stock Performance

The company has a debt-to-equity ratio of 198.17, a quick ratio of 0.53 and a current ratio of 0.66.

Insiders Place Their Bets

In related news, insider Christine Bartlett acquired 20,000 shares of the company’s stock in a transaction on Wednesday, February 28th. The stock was acquired at an average price of A$2.36 ($1.54) per share, with a total value of A$47,160.00 ($30,823.53). Company insiders own 17.64% of the company’s stock.

Australian Clinical Labs Company Profile

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.